ES2174054T3 - Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico. - Google Patents

Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.

Info

Publication number
ES2174054T3
ES2174054T3 ES96903090T ES96903090T ES2174054T3 ES 2174054 T3 ES2174054 T3 ES 2174054T3 ES 96903090 T ES96903090 T ES 96903090T ES 96903090 T ES96903090 T ES 96903090T ES 2174054 T3 ES2174054 T3 ES 2174054T3
Authority
ES
Spain
Prior art keywords
potassic
bicarbonate
sodium alginate
compositions including
including sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96903090T
Other languages
English (en)
Inventor
Paul Frederick Field
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770811&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2174054(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Application granted granted Critical
Publication of ES2174054T3 publication Critical patent/ES2174054T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL USO DE BICARBONATO POTASICO PARA LA PREPARACION DE UNA COMPOSICION LIQUIDA ACUOSA VERTIBLE QUE COMPRENDE AL MENOS UN 8 % DE ALGINATO SODICO PARA SU USO COMO PRODUCTO FARMACEUTICO.
ES96903090T 1995-03-03 1996-02-16 Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico. Expired - Lifetime ES2174054T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9504599.3A GB9504599D0 (en) 1995-03-03 1995-03-03 Improvements in or relating to organic compositions

Publications (1)

Publication Number Publication Date
ES2174054T3 true ES2174054T3 (es) 2002-11-01

Family

ID=10770811

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96903090T Expired - Lifetime ES2174054T3 (es) 1995-03-03 1996-02-16 Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.

Country Status (22)

Country Link
US (1) US5681827A (es)
EP (1) EP0813407B1 (es)
JP (1) JPH11501044A (es)
KR (1) KR19980702689A (es)
CN (1) CN1123337C (es)
AR (1) AR004168A1 (es)
AT (1) ATE218853T1 (es)
AU (1) AU696480B2 (es)
BR (2) BR9607679A (es)
CZ (1) CZ289386B6 (es)
DE (1) DE69621785T2 (es)
ES (1) ES2174054T3 (es)
GB (1) GB9504599D0 (es)
HK (1) HK1007957A1 (es)
HU (1) HUP9801414A3 (es)
NO (1) NO316207B1 (es)
NZ (1) NZ301749A (es)
PL (1) PL184245B1 (es)
PT (1) PT813407E (es)
TR (1) TR199700891T1 (es)
WO (1) WO1996027368A1 (es)
ZA (1) ZA961517B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
PL195031B1 (pl) * 1997-04-30 2007-08-31 Reckitt Benckiser Healthcare Ciekła wodna kompozycja nadająca się do nalewaniazawierająca alginian i wodorowęglan metalu alkalicznego
US6027715A (en) * 1998-03-02 2000-02-22 Pozuelo; Jose Composition and means for treating dry mouth
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP3959192B2 (ja) * 1998-12-03 2007-08-15 株式会社大塚製薬工場 経管栄養食品
US6351665B1 (en) 1999-05-07 2002-02-26 Kenneth L Koch Method and apparatus for evaluating myoelectric signals and identifying artifact
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
EP2004138B1 (en) * 2006-03-16 2013-11-20 Glycologic Limited Gastric raft composition comprising processed starches for inducing satiety
CN101641022A (zh) 2007-02-13 2010-02-03 S-生物技术控股有限责任公司 含有海藻酸盐的饮食产品
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
KR100930809B1 (ko) * 2008-02-13 2009-12-09 (주)포테이토밸리 레드킹밸리 감자의 생즙 또는 전분을 유효성분으로함유하는 위염, 위궤양 및 십이지장궤양 예방 및 치료용약학조성물
WO2010108494A1 (en) * 2009-03-25 2010-09-30 S-Biotek Holding Aps Dayspepsia treatment with alginate
KR20120108218A (ko) * 2011-03-23 2012-10-05 동아제약주식회사 위식도 역류질환 치료용 액상 타입 조성물
WO2013055251A1 (ru) * 2011-10-14 2013-04-18 Общество С Ограниченной Ответственностью "Цитонир" Пероральная фармацевтическая композиция для лечения воспалительных заболеваний желудочно-кишечного тракта
EP2806880B2 (en) * 2012-01-27 2020-04-22 Institute of Bioorganic Chemistry Pharmaceutical composition as a substance for antireflux antacid drug
US9636360B2 (en) 2012-09-18 2017-05-02 pH Science Holdings, Inc Method and composition for treating gastro-esophageal disorders
KR102303835B1 (ko) * 2014-01-08 2021-09-16 영진약품 주식회사 수성의 유동성 액체 조성물 및 이의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524740A (en) * 1976-11-09 1978-09-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions for use in the suppression of gastric reflux
US4869902A (en) * 1984-04-19 1989-09-26 Rorer Pharmaceutical Corporation Antacid composition
EP0179858B1 (en) * 1984-04-19 1992-07-01 Rhone-Poulenc Rorer International (Holdings) Inc. Antacid composition
GB8618847D0 (en) * 1986-08-01 1986-09-10 Smith Kline French Lab Pharmaceutical formulations
DK179687D0 (da) * 1987-04-08 1987-04-08 Farma Food As Praeparat
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
EP0813407B1 (en) 2002-06-12
DE69621785T2 (de) 2002-11-28
AU696480B2 (en) 1998-09-10
AU4724496A (en) 1996-09-23
CN1177292A (zh) 1998-03-25
PL184245B1 (pl) 2002-09-30
NO973964L (no) 1997-08-28
PT813407E (pt) 2002-10-31
KR19980702689A (ko) 1998-08-05
TR199700891T1 (xx) 1998-02-21
NO973964D0 (no) 1997-08-28
NO316207B1 (no) 2003-12-29
AR004168A1 (es) 1998-11-04
CZ289386B6 (cs) 2002-01-16
BR9607679A (pt) 1998-07-07
HUP9801414A2 (hu) 1999-01-28
GB9504599D0 (en) 1995-04-26
BR9607679B8 (pt) 2014-11-18
CN1123337C (zh) 2003-10-08
HUP9801414A3 (en) 2001-04-28
US5681827A (en) 1997-10-28
PL322044A1 (en) 1998-01-05
HK1007957A1 (en) 1999-04-30
EP0813407A1 (en) 1997-12-29
NZ301749A (en) 1998-05-27
ATE218853T1 (de) 2002-06-15
WO1996027368A1 (en) 1996-09-12
ZA961517B (en) 1996-09-03
DE69621785D1 (de) 2002-07-18
CZ274997A3 (cs) 1998-03-18
JPH11501044A (ja) 1999-01-26
MX9706661A (es) 1997-11-29

Similar Documents

Publication Publication Date Title
ES2174054T3 (es) Composiciones farmaceuticas acuosas liquidas que comprenden alginato sodico y bicarbonato potasico.
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
AU2845599A (en) Pharmaceutical compositions and their use
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2099438T3 (es) Polvo seco y estable de cefalosporina hidratada para formulacion de suspension oral.
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2156122T3 (es) Agentes gelificantes de xantano.
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
MY131380A (en) Fatty ingredients & products for full or partial replacement of fat in food products
IL102814A0 (en) Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
BR9611571B1 (pt) composiÇço farmacÊutica estÁvel, kit para administraÇço de ngf e produto medicinal.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
MD970269A (en) Clavulanates
IL106288A0 (en) Skin regenerating cosmetic compositions
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
AU2774292A (en) Toiletries composition
NZ510360A (en) Fish gelatinous composition for use as an ingredient in tablets
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
MX9203616A (es) Derivados de 4-amidino cromano y de 4-amidino[3,2-c] piridina y composiciones farmaceuticas que los contienen.
JPS5750914A (en) Betamethasone external pharmaceutical
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
HU9700437D0 (en) Substituted thiophenyl-alkenyl-carboxylic-acid-guanidid-derivatives, their production, their use as active component of pharmaceutical compositions, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 813407

Country of ref document: ES